Hubbry Logo
Terminal complement pathway deficiencyTerminal complement pathway deficiencyMain
Open search
Terminal complement pathway deficiency
Community hub
Terminal complement pathway deficiency
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Terminal complement pathway deficiency
from Wikipedia
Terminal complement pathway deficiency
complement membrane attack complex

Terminal complement pathway deficiency is a genetic condition affecting the complement membrane attack complex (MAC).

It involves deficiencies of C5, C6, C7, and C8. (While C9 is part of the MAC, and deficiencies have been identified,[1] it is not required for cell lysis.[2])

People with this condition are prone to meningococcal infection.[3] Vaccination may be recommended.[4]

Cause

[edit]

Diagnosis

[edit]

Suspect terminal complement pathway deficiency in patients with more than one Neisseria infection episode.

Complement tests
C4 (C) FB (A) C3 CH50 Conditions
· PSG, C3 NeF AA
· · HAE, C4D
· · · TCPD
·/↓ SLE
inflammation

Initial complement tests often include C3 and C4, but not C5 through C9. Instead, the CH50 result may play a role in diagnosis: if the CH50 level is low but C3 and C4 are normal, then analysis of the individual terminal components may be warranted.

Treatment

[edit]

Patients with terminal complement pathway deficiency should receive meningococcal and pneumococcal vaccinations. They can receive live vaccines.

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia
Add your contribution
Related Hubs
User Avatar
No comments yet.